Fibronectin, Rad51, Cyclin-E1 and Progesterone Receptor are also shown, along with supporting box plots from the IDH-wt grade II/III glioma vs GBM expression data, and demonstrated higher expression in the PN and GBM samples. This evidence concerns the gene FN1 and central nervous system cancer.